Pulmonary Embolism During Pregnancy: An Updated Review With Case Series Description

Curr Probl Cardiol. 2023 Jul;48(7):101683. doi: 10.1016/j.cpcardiol.2023.101683. Epub 2023 Mar 9.

Abstract

Pulmonary embolism (PE) is a potentially life-threatening condition that can occur during pregnancy and pose a significant risk to the mother and the developing fetus. It is a major contributor to pregnancy-related morbidity and mortality in any trimester. It is estimated that the incidence of PE during pregnancy is approximately 1 in 1000 pregnancies. The mortality rate for pregnant women with PE is about 3%, significantly higher than that for nonpregnant women with PE. Overall, the topic of PE and pregnancy is essential for healthcare professionals to be aware of the risks, signs, and treatment options to improve outcomes and ensure the best possible care for both the mother and the developing fetus. To prevent the fatal condition, the physician is encouraged when there is a suspicion of the pathology. This report presents an updated comprehensive review of PE during pregnancy, discussing critical aspects of the clinical and imaging diagnosis, use of heparin, thrombolysis, and prevention. We believe this article will be helpful for cardiologists, obstetricians, and other health-related professionals.

Publication types

  • Review

MeSH terms

  • Diagnostic Imaging
  • Female
  • Heparin / therapeutic use
  • Humans
  • Pregnancy
  • Pulmonary Embolism* / diagnosis
  • Pulmonary Embolism* / epidemiology
  • Pulmonary Embolism* / etiology

Substances

  • Heparin